Associate Professor Ciara McCabe was asked to speak about, Cannabinoids as Medicines, to the DrugScience committee led by David Nutt, Imperial College London. The DrugScience committee works to provide clear, evidence-based information without political or commercial interference.
Professor Ciara McCabe spoke about her work, which was the first to show the effects of the cannabinoid neutral antagonist THCv on the neural response to reward in humans. This work has been used as evidence to review the scheduling of cannabinoids in the UK. Cannabinoids are currently under Schedule 1, which makes them difficult to study.